Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) EBITDA Margin (2021 - 2025)

Biote has reported EBITDA Margin over the past 5 years, most recently at 59.27% for Q4 2025.

  • Quarterly results put EBITDA Margin at 59.27% for Q4 2025, up 11516.0% from a year ago — trailing twelve months through Dec 2025 was 18.72% (up 2666.0% YoY), and the annual figure for FY2025 was 16.44%, up 1643.0%.
  • EBITDA Margin for Q4 2025 was 59.27% at Biote, up from 17.66% in the prior quarter.
  • Over the last five years, EBITDA Margin for BTMD hit a ceiling of 59.27% in Q4 2025 and a floor of 206.21% in Q2 2022.
  • Median EBITDA Margin over the past 5 years was 0.02% (2025), compared with a mean of 6.12%.
  • Biggest five-year swings in EBITDA Margin: tumbled -20624bps in 2022 and later soared 20621bps in 2023.
  • Biote's EBITDA Margin stood at 16.26% in 2021, then grew by 5bps to 17.09% in 2022, then plummeted by -396bps to 50.55% in 2023, then dropped by -11bps to 55.89% in 2024, then soared by 206bps to 59.27% in 2025.
  • The last three reported values for EBITDA Margin were 59.27% (Q4 2025), 17.66% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.